IN8bio, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| INAB | GDTC | TCRX | INMB | ATORX.ST | MBIO | |
|---|---|---|---|---|---|---|
| Market cap | 9.18M | 10.61M | 14.23M | 41.18M | 38.89M | 3.14M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.0 | -5.9 | -0.4 | -3.1 | -0.1 | -1.2 |
| Price/book | 0.5 | 2.7 | 0.2 | 1.8 | 0.3 | 0.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −41.72% | −56.87% | −83.35% | −25.42% | −99.41% | −69.02% |
| Today | −2.02% | −2.31% | +11.11% | +0.76% | +1.87% | +1.07% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All INAB news ›Analysts’ Top Healthcare Picks: IN8bio (INAB), Daré Bioscience (DARE)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IN8bio (INAB), Daré Bioscience (DARE) and NovaBridge Biosciences (NBP) with bullish sentiments. H.C. Wainwright analyst Swayampakula Ramakanth…
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
The employee must remain employed on each vesting date to earn the option over its four-year vesting period. IN8bio (INAB) granted a new employee a stock option covering 60,000 common shares, with a grant date of October 1, 2026. Prior…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- globenewswire.com1
- markets.businessinsider.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.